Use of Oral Anticoagulation in Patients With Atrial Fibrillation and End-stage Renal Disease: What Is Needed Nowadays? Response

Maria Mahmood; Professor Gregory Lip

doi:10.1016/j.rec.2018.08.002

Related publications

Article2018

Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction

Tatjana Potpara, Charles J. Ferro, Professor Gregory Lip

Article2018

Oral Anticoagulation in Very Elderly Patients With Atrial Fibrillation

Tze‐Fan Chao, Chia‐Jen Liu, Yenn‐Jiang Lin, Shih‐Lin Chang, Li‐Wei Lo, Yu‐Feng Hu, Ta‐Chuan Tuan, Jo‐Nan Liao, Fa‐Po Chung, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Article2016

Current Status and Time Trends of Oral Anticoagulation Use Among Chinese Patients With Nonvalvular Atrial Fibrillation

Sanshuai Chang, Jianzeng Dong, Changsheng Ma, Xin Du, Jiahui Wu, Ribo Tang, Shijun Xia, Xueyuan Guo, Ronghui Yu, Deyong Long, Rong Bai, Nian Liu, Caihua Sang, Chenxi Jiang, Xiaohui Liu, Jianhong Pan, Professor Gregory Lip

Article2021

Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation

P. H. Kevin Chang, Wei‐Ting Wang, Yi‐Wen Tsai, Hao‐Min Cheng, Wei-Lun Wu, Hui‐Chin Chang, Chen‐Huan Chen, Shih‐Hwa Chiou, Professor Gregory Lip, Chern‐En Chiang

Article2021

Hypertension control and end-stage renal disease in atrial fibrillation: a nationwide population-based cohort study

Soonil Kwon, So-Ryoung Lee, Eue-Keun Choi, Jin‐Hyung Jung, Kyungdo Han, Seil Oh, Professor Gregory Lip